A Novel Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplant in Patients Aged ≥ 40 Years Old With Severe Aplastic Anemia: a Multicenter, Single-arm, Observational Clinical Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The goal of this prospective, multicenter, single arm observational study is to evaluate the efficacy and safety of the BFCA regimen in ≥ 40 years old SAA patients undergoing haplo-HSCT.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 60
Healthy Volunteers: f
View:
• Severe aplastic anemia;
• Aged 40-60 years old;
• Weight 45Kg-100Kg;
• Eastern Cooperative Oncology Group (ECOG) score ≤3;
• No major organ injury (ECG ejection fraction \>45%; bilirubin \< 2 times the upper limit of normal value; AST and ALT \< 3 times the upper limit of normal value; serum creatinine \< 2 times the upper limit of normal value);
• No severe infection;
• Subjects voluntarily participated in this clinical trial and signed the informed consent.
Locations
Other Locations
China
Peking Universtiy Peoples' Hospital
RECRUITING
Beijing
Contact Information
Primary
Tingting Han
htt1984.love@163.com
8601088326666
Time Frame
Start Date: 2026-06
Estimated Completion Date: 2029-12-30
Participants
Target number of participants: 64
Treatments
Peking unviversity Peoples' Hospital
The First Affiliated Hospital of Soochow University
Guangzhou First People's Hospital,
The First Affiliated Hospital of USTC
Related Therapeutic Areas
Sponsors
Leads: Peking University People's Hospital